189 related articles for article (PubMed ID: 17703695)
1. [Treatment in every detected virus replication. New guideline for therapy of hepatitis B publicized].
MMW Fortschr Med; 2007 Jul; 149(29-30):61. PubMed ID: 17703695
[No Abstract] [Full Text] [Related]
2. [New first line therapy of chronic hepatitis B. Primary therapy goal: effective virus suppression].
MMW Fortschr Med; 2007 Jul; 149(29-30):60. PubMed ID: 17703694
[No Abstract] [Full Text] [Related]
3. [The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].
Lin Q; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):722-5. PubMed ID: 19874684
[No Abstract] [Full Text] [Related]
4. Treatment of chronic hepatitis B: focus on telbivudine.
Lui YY; Chan HL
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
[TBL] [Abstract][Full Text] [Related]
5. On-treatment monitoring of chronic hepatitis B virus infection: an Asian-Pacific perspective.
Chien RN
J Gastroenterol Hepatol; 2010 May; 25(5):852-7. PubMed ID: 20546437
[TBL] [Abstract][Full Text] [Related]
6. Novel anti-hepatitis B agents: A focus on telbivudine.
Jones R; Nelson M
Int J Clin Pract; 2006 Oct; 60(10):1295-9. PubMed ID: 16981973
[TBL] [Abstract][Full Text] [Related]
7. Telbivudine in the treatment of chronic hepatitis B.
Nash K
Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis B: who to treat and which choice of treatment?
Di Marco V; Craxì A
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):281-91. PubMed ID: 19344242
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.
Brown A; Goodman Z
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):187-98. PubMed ID: 22375524
[TBL] [Abstract][Full Text] [Related]
10. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
Zarski JP
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
[No Abstract] [Full Text] [Related]
11. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy for chronic hepatitis B.
Jafri SM; Lok AS
Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
[TBL] [Abstract][Full Text] [Related]
13. [Telbivudine in the treatment of the chronic B hepatitis].
Butí MA
Gastroenterol Hepatol; 2008 Apr; 31(4):258-63. PubMed ID: 18405491
[No Abstract] [Full Text] [Related]
14. [A study on the factors correlated to virological response in chronic hepatitis B patients with telbivudine treatment].
Hu JG; Jiang JN; Su MH; Ge SF; Jiang ZC; Zhu MQ; Liu ZH; Liang YX; Guo WW
Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):787-8. PubMed ID: 21059300
[No Abstract] [Full Text] [Related]
15. Telbivudine (Tyzeka) for chronic Hepatitis B.
Med Lett Drugs Ther; 2007 Jan; 49(1253):11-2. PubMed ID: 17261968
[No Abstract] [Full Text] [Related]
16. Chronic hepatitis B: early viral suppression and long-term outcomes of therapy with oral nucleos(t)ides.
Nguyen MH; Keeffe EB
J Viral Hepat; 2009 Mar; 16(3):149-55. PubMed ID: 19236641
[TBL] [Abstract][Full Text] [Related]
17. Telbivudine.
Dienstag J; Easley C; Kirkpatrick P
Nat Rev Drug Discov; 2007 Apr; 6(4):267-8. PubMed ID: 17458000
[No Abstract] [Full Text] [Related]
18. [Telbivudine in the management of HIV/HBV coinfection. Treating hepatitis B without HIV trouble].
MMW Fortschr Med; 2009 Apr; 151(18):62-3. PubMed ID: 19769080
[No Abstract] [Full Text] [Related]
19. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
Liaw YF; Gane E; Leung N; Zeuzem S; Wang Y; Lai CL; Heathcote EJ; Manns M; Bzowej N; Niu J; Han SH; Hwang SG; Cakaloglu Y; Tong MJ; Papatheodoridis G; Chen Y; Brown NA; Albanis E; Galil K; Naoumov NV;
Gastroenterology; 2009 Feb; 136(2):486-95. PubMed ID: 19027013
[TBL] [Abstract][Full Text] [Related]
20. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
Dusheiko G
Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
